A Randomized, Double-Blind, Parallel Arm Study of the Efficacy and Safety of Investigational Dulaglutide Doses When Added to Metformin in Patients With Type 2 Diabetes Mellitus
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Nov 2018
At a glance
- Drugs Dulaglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Acronyms AWARD-11
- Sponsors Eli Lilly
- 09 Oct 2018 Planned End Date changed from 3 Oct 2019 to 7 Oct 2019.
- 09 Oct 2018 Planned primary completion date changed from 10 May 2019 to 20 May 2019.
- 01 Oct 2018 Status changed from recruiting to active, no longer recruiting.